Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
32.58
+0.26 (0.81%)
At close: Oct 8, 2025, 4:00 PM EDT
32.58
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:15 PM EDT
HRTS Holdings Information
HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 8.48%, UnitedHealth Group at 4.99%, AstraZeneca at 4.39%, Abbott Laboratories at 4.37%, and Roche Holding AG at 4.34%.
Total Holdings
45
Top 10 Percentage
44.12%
Asset Class
Equity
ETF Category
Health
Assets
51.68M
PE Ratio
19.66
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 8.48% |
2 | UNH | UnitedHealth Group Incorporated | 4.99% |
3 | LON: AZN | AstraZeneca PLC | 4.39% |
4 | ABT | Abbott Laboratories | 4.37% |
5 | RHHBY | Roche Holding AG | 4.34% |
6 | GILD | Gilead Sciences, Inc. | 3.67% |
7 | TMO | Thermo Fisher Scientific Inc. | 3.64% |
8 | BSX | Boston Scientific Corporation | 3.50% |
9 | CPH: NOVO.B | Novo Nordisk A/S | 3.39% |
10 | ABBV | AbbVie Inc. | 3.34% |
11 | MDT | Medtronic plc | 3.18% |
12 | SWX: NOVN | Novartis AG | 3.16% |
13 | BBIO | BridgeBio Pharma, Inc. | 2.91% |
14 | DHR | Danaher Corporation | 2.47% |
15 | MRK | Merck & Co., Inc. | 2.44% |
16 | VRTX | Vertex Pharmaceuticals Incorporated | 2.42% |
17 | CYTK | Cytokinetics, Incorporated | 2.38% |
18 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.27% |
19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.23% |
20 | REGN | Regeneron Pharmaceuticals, Inc. | 2.04% |
21 | AMGN | Amgen Inc. | 2.03% |
22 | EW | Edwards Lifesciences Corporation | 1.88% |
23 | MCK | McKesson Corporation | 1.80% |
24 | BMY | Bristol-Myers Squibb Company | 1.77% |
25 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.77% |
As of Oct 3, 2025